Ozempic/Wegovy Tracker App
Track Your Ozempic/Wegovy Protocol
Ozempic/Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Ozempic/Wegovy protocol — doses, side effects, weight, and labs.
What Is Ozempic/Wegovy?
Ozempic/Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Ozempic/Wegovy protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Ozempic/Wegovy protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Ozempic/Wegovy protocol record from day one.
How to Track Your Ozempic/Wegovy Protocol
Ozempic/Wegovy Key Facts
Protocol FAQs
Log each injection in Shotlee with the dose, date, injection site, and any side effects. Shotlee keeps a complete timeline of your Ozempic/Wegovy protocol.
Yes. Shotlee supports tracking multiple medications and peptides simultaneously, including combination protocols.
Record every dose, injection site, timing, any side effects, and weekly weight/measurements. This data helps you and your prescriber optimize your protocol.
Yes. Shotlee is completely free for dose logging, side effect tracking, and protocol management. No hidden fees.
Open the Shotlee app, navigate to the dose logging screen, select Sermaglutide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Ozempic/Wegovy Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Semaglutide
What's the Deal with Peptides? The Hyped Market Under FDA Review
An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.
8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.
8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.
7 min read